What lessons can we learn from NOS knockout mice in acute pulmonary disease?

Critical Care Medicine

Volumn 30, Issue 9, 2002, Pages 2143-2145

  Scott, Jeremy A ^a   Marsden, Philip A ^a   Slutsky, Arthur S ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Lung; Nitric oxide; Sepsis

Indexed keywords

ARGININE; CITRULLINE; CYTOKINE; ENDOTHELIUM DERIVED RELAXING FACTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BRONCHOSPASM; CYTOKINE PRODUCTION; EDITORIAL; GRAM NEGATIVE INFECTION; HYPOXIA; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; LUNG INJURY; LUNG VASOCONSTRICTION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SMOOTH MUSCLE TONE;

EID: 0036741485     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200209000-00033     Document Type: Editorial

References (24)

1. Shanley TP, Zhao B, Macariola DR, et al: Role of nitric oxide in acute lung inflammation: Lessens learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med 2002; 30:1960-1968
2. Bult H, Boeckxtaens GE, Pelckmans PA, et al: Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990; 345:346-347
3. Ignarro LJ, Buga GM, Byrns RE: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84-9265-9269
4. Moncada S, Higgs A, Furchgott R: International union of pharmacology: Nomenclature in nitric oxide research. Pharmacol Rev 1997; 49:137-142
5. Avontuur JA, Nolthenius RP, Buijk SL, et al: Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest 1998; 113: 1640-1646
6. Grover R, Zaccardelli D, Colice G, et al: An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546c88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 1999; 27:913-922
7. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
8. Laubach VE, Shesely EG, Smithies O, et al: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 1995; 92:10688-10692
9. MacMicking JD, Nathan C, Hom G, et al: Altered responses to infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650
10. Fagan KA, Tyler RC, Sato K, et al: Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol 1999; 277: L472-L478
11. Huang PL, Dawson TM, Bredt DS, et al: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75:1273-1286
12. De Sanctis G, MacLean J, Hamada K, et al: Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 1999; 189:1621-1629
13. Gunnett CA, Chu Y, Heistad DD, et al: Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol 1998; 44:H416-H421
14. Cobb JP, Hotchkiss RS, Swanson PE, et al: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999; 126:438-442
15. Kakuyama M, Ahluwalia A, Rodrigo J, et al: Cholinergic contraction is altered in nNOS knockouts: Cooperative modulation of neural bronchoconstriction by nNOS and COX. Am J Respir Crit Care Med 1999; 160:2072-2078
16. De Sanctis GT, Mehta S, Kobzik L, et al: Contribution of type I NOS to expired gas NO and bronchial responsiveness in mice. Am J Physiol 1997; 273:L883-L888
17. Fagan KA, Fouty BW, Tyler RC, et al: The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 1999; 103:291-299
18. Quinlan TR, Li D, Laubach VE, et al: eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2000; 279:L641-L650
19. Preston IR, Klinger JR, Houtchens J, et al: Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome. Chest 2002; 121:656-659
20. Razavi HM, Werhun R, Scott JA, et al: Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med 2002; 30:868-873
21. Shah NS, Nakayama DK, Jacob TD, et al: Efficacy of inhaled nitric oxide in oleic acid-induced acute lung injury. Crit Care Med 1997; 25:153-158
22. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999; 25:911-919
23. Dellinger RP, Zimmerman JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase ii trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998; 26:15-23
24. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308